A set of policy principles to meet the global challenge of Rare Diseases
Rare Diseases: shaping a future with no-one left behind
G-FINDER Report 2016: The biopharmaceutical industry confirms its status as a significant funder of neglected disease R&D
Leadership rotation at Fight the Fakes, the worldwide campaign to protect people from fake medicines
Thomas Cueni takes helm of IFPMA as Director General
IFPMA and the IAEA through its Programme of Action for Cancer Therapy (PACT) join forces to make a difference in comprehensive cancer control
IFPMA statement on the entry in force of the TRIPS “Paragraph 6” amendment
EFPIA – IFPMA Statement in response to the OECD Health Committee Ministerial Statement
Ian C. Read Elected New President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) head announces departure
The Exciting Journey from Flu Virus to Vaccine- Surveillance activities
The Exciting Journey from Flu Virus to Vaccine- Surveillance activities
Export Manufacturing Exemption during SPC/PTR Extended Patent Term: Global Position
Global Biopharmaceutical Industry Takes Action to Combat Antimicrobial Resistance (AMR)
Industry Roadmap for Progress on Combating Antimicrobial Resistance
Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance
IFPMA 2016 interview series on '@ preICDRA2016 - What to expect?'
The Evolution of access to essential medicines for the treatment of HIV/AIDS
What’s needed for a strong regulatory system in Africa
IFPMA Guidelines on Access to Genetic Resources: position paper
Combating hypertension
Hypertension: putting the pressure on the silent killer
Partnership launched to tackle cervical cancer in Africa
Improving the odds for early diagnosis of cervical cancer in Africa
IFPMA 2016 Geneva Pharma Forum on Biotherapeutics - Long version
Import Testing: position papers
Pharmacovigilance (French): Do your bit, play your part!
Pharmacovigilance (Arabic): Do your bit, play your part!
2016 Geneva Pharma Forum Highlights on Biotherapeutics
Pharmacovigilance: Do your bit, play your part!

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Assembly Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Efficacy Epidemics Ethics Event Highlights Fake Medicines Fakes Fight the Fakes Flu Global Health global health security harmonization Health Partnerships HIV/AIDS IFPMA IFPMA Statement Immunization Incremental Innovation Influenza Influenza Vaccination Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Transparency Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers